{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:48:14Z","timestamp":1792874894905,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC\u20132013\u2013CoG 614739\u2013A_HERO"],"award-info":[{"award-number":["ERC\u20132013\u2013CoG 614739\u2013A_HERO"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jpba.2018.01.030","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T06:47:38Z","timestamp":1517381258000},"page":"339-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Evaluation of a novel micro-sampling device, Mitra\u2122, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural C\u00f4te d\u2019Ivoire"],"prefix":"10.1016","volume":"151","author":[{"given":"Jana","family":"Kova\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Panic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Neodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean T.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.01.030_bib0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.01.030_bib0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/adc.2009.177592","article-title":"Facilitating pharmacokinetic studies in children: a new use of dried blood spots","volume":"95","author":"Patel","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jpba.2018.01.030_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2015-010484","article-title":"Invasiveness of pharmacokinetic studies in children: a systematic review","volume":"6","author":"Altamimi","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpba.2018.01.030_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/1539-6924.00295","article-title":"Differences in pharmacokinetics between children and adults \u2212 II. Children\u2019s variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling","volume":"23","author":"Hattis","year":"2003","journal-title":"Risk Anal."},{"key":"10.1016\/j.jpba.2018.01.030_bib0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/pharmaceutics2040364","article-title":"Drug development for pediatric populations: regulatory aspects","volume":"2","author":"Zisowsky","year":"2010","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2018.01.030_bib0030","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/AAC.02139-13","article-title":"Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants","volume":"58","author":"Cohen-Wolkowiez","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2018.01.030_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpba.2015.01.052","article-title":"Quantitative bioanalysis of paracetamol in rats using volumetric absorptive microsampling (VAMS)","volume":"108","author":"Denniff","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.01.030_bib0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1208\/s12248-010-9188-y","article-title":"Use of dried blood spots in drug development: pharmacokinetic considerations","volume":"12","author":"Rowland","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2018.01.030_bib0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpba.2018.01.030_bib0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1353\/dem.2007.0038","article-title":"What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research","volume":"44","author":"McDade","year":"2007","journal-title":"Demography"},{"key":"10.1016\/j.jpba.2018.01.030_bib0055","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/jn\/131.5.1631S","article-title":"Use of filter paper for the collection and analysis of human whole blood specimens","volume":"131","author":"Mei","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.jpba.2018.01.030_bib0060","first-page":"1","article-title":"Volumetric absorptive microsampling: current advances and applications","author":"Kok","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.01.030_bib0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.aca.2015.04.056","article-title":"Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study","volume":"881","author":"De Kesel","year":"2015","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jpba.2018.01.030_bib0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated with blood hematocrit","volume":"7","author":"Spooner","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.01.030_bib0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2125.2012.04392.x","article-title":"Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants","volume":"75","author":"Patel","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.01.030_bib0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1373\/clinchem.2015.247668","article-title":"Effect of dried blood spot quality on newborn screening analyte concentrations and recommendations for minimum acceptance criteria for sample analysis","volume":"62","author":"George","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2018.01.030_bib0085","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2018.01.030_bib0090","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4155\/bio.14.151","article-title":"Current strategies for coping with the hematocrit problem in dried blood spot analysis","volume":"6","author":"De Kesel","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.01.030_bib0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpba.2016.12.012","article-title":"Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples","volume":"135","author":"Kip","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.01.030_bib0100","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4155\/bio.15.181","article-title":"Hepcidin determination in dried blood by microfluidic LC\u2013MS\/MS: comparison of DBS and volumetric absorptive microsampling for matrix effect and recovery","volume":"7","author":"Houbart","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.01.030_bib0105","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.4155\/bio.15.126","article-title":"Evaluation of two blood microsampling approaches for drug discovery PK studies in rats","volume":"7","author":"Luo","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.01.030_bib0110","series-title":"Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry","author":"Food and Drug Administration","year":"2015"},{"issue":"January (118)","key":"10.1016\/j.jpba.2018.01.030_bib0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpba.2015.10.011","article-title":"Development and validation of an enantioselective LC-MS\/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spots","volume":"25","author":"Meister","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.01.030_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02253-17","article-title":"Pharmacokinetics of praziquantel in Schistosoma mansoni and Schistosoma haematobium infected school- and preschool- aged children","author":"Kova\u010d","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2018.01.030_bib0125","series-title":"Guidance for Industry: Bioanalytical Method Validation","author":"FDA","year":"2013"},{"key":"10.1016\/j.jpba.2018.01.030_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11613\/BM.2015.015","article-title":"Understanding bland altman analysis","volume":"25","author":"Giavarina","year":"2015","journal-title":"Biochem. Medica."},{"key":"10.1016\/j.jpba.2018.01.030_bib0135","doi-asserted-by":"crossref","DOI":"10.1186\/1756-3305-5-298","article-title":"Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children","volume":"5","author":"Stete","year":"2012","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.jpba.2018.01.030_bib0140","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical ctudies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"Spooner","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2018.01.030_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004700","article-title":"Pharmacokinetic study of praziquantel enantiomers and its main metabolite R-trans-4-OH-PZQ in plasma, blood and dried blood spots in Opisthorchis viverrini-infected patients","volume":"10","author":"Meister","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jpba.2018.01.030_bib0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"Olliaro","year":"2014","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517326821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517326821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:54:33Z","timestamp":1760000073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517326821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"alternative-id":["S0731708517326821"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.01.030","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a novel micro-sampling device, Mitra\u2122, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural C\u00f4te d\u2019Ivoire","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}